MedPage Today (2/19, Gever) reports that the Food and Drug Administration announced that Gilead Sciences has issued a voluntary recall for “one lot of cidofovir for intravenous infusion (Vistide),” which is used to treat cytomegalovirus (CMV) retinitis in patients with AIDS, because of some vials contain an unknown particulate. The recall “involves lot number B120217A, with an expiration […]
